Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Aug;16(4):197-204.
doi: 10.1016/j.siny.2011.05.004. Epub 2011 Jun 15.

Mitochondrial disorders caused by mutations in respiratory chain assembly factors

Affiliations
Review

Mitochondrial disorders caused by mutations in respiratory chain assembly factors

Francisca Diaz et al. Semin Fetal Neonatal Med. 2011 Aug.

Abstract

Mitochondrial diseases involve the dysfunction of the oxidative phosphorylation (OXPHOS) system. This group of diseases presents with heterogeneous clinical symptoms affecting mainly organs with high energy demands. Defects in the multimeric complexes comprising the OXPHOS system have a dual genetic origin, mitochondrial or nuclear DNA. Although many nuclear DNA mutations involve genes coding for subunits of the respiratory complexes, the majority of mutations found to date affect factors that do not form part of the final complexes. These assembly factors or chaperones have multiple functions ranging from cofactor insertion to proper assembly/stability of the complexes. Although significant progress has been made in the last few years in the discovery of new assembly factors, the function of many remains elusive. Here, we describe assembly factors or chaperones that are required for respiratory chain complex assembly and their clinical relevance.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement

Nothing to declare.

Figures

Figure 1
Figure 1
BCS1L is encoded by eight exons with the start codon in exon 2 and the stop codon in exon 8. Mutations in the 5′UTR region causing complex III deficiency are shown. In the BCS1L protein three functional domains, the import domain, the BCS1L_N-specific domain and the AAA_ATPase domain can be identfied. BCS1L mutations are indicated by their respective amino acid exchange. Mutations occur in all domains of the protein but cause a wide spectrum of symptoms ranging from mild complex III deficiency and Björnstad syndrome (shown above the BCS1L protein) to mutations causing mainly hepatopathy (bold, italic), mainly encephalopathy (underlined) or hepatopathy and encephalopathy (bold, italic and underlined) (shown below the BCS1L protein). BCS1L mutations are indicated by their respective amino acid exchange. Patients identified so far are either homozygous for mutations (P99L, S277N, S78G, T50A, G129R) or compound heterozygotes (R45C/R56ter, V327A/R56ter, G35R/184C, S78G/144Q, R73C/F368I, R155P/V353M).

References

    1. Schaefer AM, Taylor RW, Turnbull DM, et al. The epidemiology of mitochondrial disorders – past, present and future. Biochim Biophys Acta. 2004;1659:115–120. - PubMed
    1. Cree LM, Samuels DC, Chinnery PF. The inheritance of pathogenic mitochondrial DNA mutations. Biochim Biophys Acta. 2009;1792:1097–1092. - PMC - PubMed
    1. Kerr DS. Treatment of mitochondrial electron transport chain disorders: a review of clinical trials over the past decade. Molec Genet Metab. 2010;99:246–255. - PubMed
    1. Wenz T, Williams SL, Bacman SR, et al. Emerging therapeutic approaches to mitochondrial diseases. Dev Disabil Res Rev. 2010;16:219–229. - PubMed
    1. Clason T, Ruiz T, Schagger H, et al. The structure of eukaryotic and prokaryotic complex I. J Struct Biol. 2010;169:81–88. - PMC - PubMed

Publication types

MeSH terms

Substances